These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20939815)

  • 21. ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.
    Shi S; Fu L; Yi J; Yang Z; Zhang X; Deng Y; Wang W; Wu C; Zhao W; Hou T; Zeng X; Lyu A; Cao D
    Nucleic Acids Res; 2024 Jul; 52(W1):W439-W449. PubMed ID: 38783035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal design for high-throughput screening via false discovery rate control.
    Feng T; Basu P; Sun W; Ku HT; Mack WJ
    Stat Med; 2019 Jul; 38(15):2816-2827. PubMed ID: 30924183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harvesting classification trees for drug discovery.
    Yuan Y; Chipman HA; Welch WJ
    J Chem Inf Model; 2012 Dec; 52(12):3169-80. PubMed ID: 23110407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual screening: are we there yet?
    Jalaie M; Shanmugasundaram V
    Mini Rev Med Chem; 2006 Oct; 6(10):1159-67. PubMed ID: 17073716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
    Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
    J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The compromise of virtual screening and its impact on drug discovery.
    Slater O; Kontoyianni M
    Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
    [No Abstract]   [Full Text] [Related]  

  • 29. A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA).
    Alagappan M; Jiang D; Denko N; Koong AC
    Adv Exp Med Biol; 2016; 899():253-68. PubMed ID: 27325272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consistent Cell-selective Analog Series as Constellation Luminaries in Chemical Space.
    Naveja JJ; Medina-Franco JL
    Mol Inform; 2020 Dec; 39(12):e2000061. PubMed ID: 32390313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of data integrity on decision making in early lead discovery.
    Beck B; Seeliger D; Kriegl JM
    J Comput Aided Mol Des; 2015 Sep; 29(9):911-21. PubMed ID: 26409840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothesis testing in high-throughput screening for drug discovery.
    Prummer M
    J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays.
    Zhang JH; Kang ZB; Ardayfio O; Ho PI; Smith T; Wallace I; Bowes S; Hill WA; Auld DS
    J Biomol Screen; 2014 Jun; 19(5):651-60. PubMed ID: 24246376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual high throughput screening in new lead identification.
    Badrinarayan P; Sastry GN
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):840-60. PubMed ID: 21843146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of HT-ADME in drug discovery.
    Morgan D
    Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Testing of Druglike Screening Libraries.
    Wang J; Ge Y; Xie XQ
    J Chem Inf Model; 2019 Jan; 59(1):53-65. PubMed ID: 30563329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.